Non-adherence results in massive costs for the health system and an enormous loss of potential revenue for the pharmaceutical industry. Interventions to improve medication adherence should be top priority for pharmaceutical companies and will prove beneficial to all stakeholders. Increasing adherence rates by only 10% would translate into billions of dollars of pharmaceutical revenue opportunities in the US alone.
Click the banner to visit the full conference website.
This summit brings together a variety of different key stakeholders to discuss how they can partner with the pharmaceutical industry to improve patient adherence. Academia shares the latest findings in adherence research; technology providers give an update on innovative tools to engage patients and assist them; advocacy groups outline patient needs and share best practices on how to raise awareness; and the industry analyzes how successful collaborations, adherence programs and effective marketing have resulted in behavioral changes.
Fill out the form to the right to gain access to the full conference agenda.
Click here to register and be sure to mention Priority Code C559EVVNT.